Gamma Medica-Ideas (GM-I) was formed by the merger in mid 2005 of Gamma
Medica, Inc., based in Northridge, CA, USA, and Ideas ASA of Oslo, Norway.
GM-I designs, develops and manufactures next-generation imaging systems for
both clinical and pre-clinical applications.
The company is a worldwide leader in multimodality pre-clinical imaging.
GM-I was first to market with MicroSPECT(R), and its X-SPECT(R) system is
the market leader in the pre-clinical SPECT category.
GM-I's X-PET(TM) system has the highest sensitivity and largest axial
field of view among pre-clinical PET systems. The company's X-O(TM) system
is a standalone micro-CT instrument that can perform full body scans on a
wide range of test subjects in less than a minute, making it one of the
fastest such systems in the industry. All three systems share a common
gantry and are part of the company's FLEX(TM) platform of pre-clinical
imaging systems. Any two systems can be combined in the common gantry, as
can all three.
GM-I's pre-clinical imaging systems are deployed by medical researchers
and drug companies that use in-vivo imaging techniques and molecular markers
to dramatically speed up studies of disease progression and therapy.